The University of Chicago Header Logo

Connection

Ayodeji Adegunsoye to Humans

Back to Details
This is a "connection" page, showing publications Ayodeji Adegunsoye has written about Humans.
Ayodeji Adegunsoye
Connection Strength
1.216
Humans
  1. Potential of phosphodiesterase 4B inhibitors in the treatment of interstitial lung disease associated with autoimmune diseases. Clin Exp Rheumatol. 2025 Jan; 43(1):119-125.
    View in: PubMed
    Score: 0.028
  2. Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine. Am J Respir Crit Care Med. 2024 Aug 15; 210(4):401-423.
    View in: PubMed
    Score: 0.028
  3. Use of Race-Specific Equations in Pulmonary Function Tests Impedes Potential Eligibility for Care and Treatment of Pulmonary Fibrosis. Ann Am Thorac Soc. 2024 Aug; 21(8):1156-1165.
    View in: PubMed
    Score: 0.028
  4. Machine learning classifier is associated with mortality in interstitial lung disease: a retrospective validation study leveraging registry data. BMC Pulm Med. 2024 May 23; 24(1):254.
    View in: PubMed
    Score: 0.028
  5. Induced Pluripotent Stem Cells in Disease Biology and the Evidence for Their In Vitro Utility. Annu Rev Genet. 2023 11 27; 57:341-360.
    View in: PubMed
    Score: 0.026
  6. Tobacco smoking is associated with combined pulmonary fibrosis and emphysema and worse outcomes in interstitial lung disease. Am J Physiol Lung Cell Mol Physiol. 2023 08 01; 325(2):L233-L243.
    View in: PubMed
    Score: 0.026
  7. Interstitial lung disease: a decade of progress and hope. Lancet Respir Med. 2023 06; 11(6):510-512.
    View in: PubMed
    Score: 0.026
  8. Racial Disparities Among Lung Transplant Survivors-Shadows and Substance. JAMA Netw Open. 2023 04 03; 6(4):e238285.
    View in: PubMed
    Score: 0.026
  9. Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts. Nat Commun. 2023 03 17; 14(1):1489.
    View in: PubMed
    Score: 0.026
  10. Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis. Immunol Allergy Clin North Am. 2023 05; 43(2):209-228.
    View in: PubMed
    Score: 0.025
  11. Evaluation of Pulmonary Fibrosis Outcomes by Race and Ethnicity in US Adults. JAMA Netw Open. 2023 03 01; 6(3):e232427.
    View in: PubMed
    Score: 0.025
  12. Inhaled Nitric Oxide for Fibrotic Interstitial Lung Disease: A Step Forward. Ann Am Thorac Soc. 2022 04; 19(4):536-538.
    View in: PubMed
    Score: 0.024
  13. High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease. Sci Rep. 2021 11 24; 11(1):22821.
    View in: PubMed
    Score: 0.023
  14. Racial Disparities in Pulmonary Fibrosis and the Impact on the Black Population. Arch Bronconeumol. 2022 08; 58(8):590-592.
    View in: PubMed
    Score: 0.023
  15. Risk, Race, and Structural Racism. Ann Am Thorac Soc. 2021 08; 18(8):1289-1290.
    View in: PubMed
    Score: 0.023
  16. The Progression to Interstitial Lung Disease: Vicarious Facts About Visceral Fat. Chest. 2021 08; 160(2):400-402.
    View in: PubMed
    Score: 0.023
  17. Diagnostic Classification of Interstitial Lung Disease in Clinical Practice. Clin Chest Med. 2021 06; 42(2):251-261.
    View in: PubMed
    Score: 0.023
  18. Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapies. EBioMedicine. 2021 05; 67:103373.
    View in: PubMed
    Score: 0.022
  19. Anticoagulation and Pulmonary Fibrosis: Friends, Foes, or Functional Allies? Chest. 2021 04; 159(4):1321-1323.
    View in: PubMed
    Score: 0.022
  20. Leukocyte telomere length and mycophenolate therapy in chronic hypersensitivity pneumonitis. Eur Respir J. 2021 03; 57(3).
    View in: PubMed
    Score: 0.022
  21. Association of Black Race with Outcomes in COVID-19 Disease: A Retrospective Cohort Study. Ann Am Thorac Soc. 2020 10; 17(10):1336-1339.
    View in: PubMed
    Score: 0.022
  22. CPAP Adherence, Mortality, and Progression-Free Survival in Interstitial Lung Disease and OSA. Chest. 2020 10; 158(4):1701-1712.
    View in: PubMed
    Score: 0.021
  23. Circulating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary Fibrosis. Chest. 2020 10; 158(4):1526-1534.
    View in: PubMed
    Score: 0.021
  24. MUC5B promoter variant: genomic fingerprint for early identification of undiagnosed pulmonary fibrosis. Thorax. 2019 12; 74(12):1111-1112.
    View in: PubMed
    Score: 0.020
  25. Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases. Ann Am Thorac Soc. 2019 05; 16(5):580-588.
    View in: PubMed
    Score: 0.020
  26. Reply to Lescoat et al. and to Khamis et al. Am J Respir Crit Care Med. 2019 04 15; 199(8):1041-1042.
    View in: PubMed
    Score: 0.019
  27. Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation. Am J Respir Crit Care Med. 2019 03 15; 199(6):747-759.
    View in: PubMed
    Score: 0.019
  28. Diagnostic Delay in Idiopathic Pulmonary Fibrosis: Where the Rubber Meets the Road. Ann Am Thorac Soc. 2019 03; 16(3):310-312.
    View in: PubMed
    Score: 0.019
  29. Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease. Chest. 2019 05; 155(5):1026-1040.
    View in: PubMed
    Score: 0.019
  30. African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysis. Eur Respir J. 2018 06; 51(6).
    View in: PubMed
    Score: 0.018
  31. Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort. Chest. 2018 02; 153(2):349-360.
    View in: PubMed
    Score: 0.017
  32. Interstitial Pneumonia With Autoimmune Features: Value of Histopathology. Arch Pathol Lab Med. 2017 Jul; 141(7):960-969.
    View in: PubMed
    Score: 0.017
  33. Comprehensive Care of the Lung Transplant Patient. Chest. 2017 07; 152(1):150-164.
    View in: PubMed
    Score: 0.016
  34. Therapeutic Approach to Adult Fibrotic Lung Diseases. Chest. 2016 Dec; 150(6):1371-1386.
    View in: PubMed
    Score: 0.016
  35. Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features. Respir Med. 2016 05; 114:53-60.
    View in: PubMed
    Score: 0.016
  36. Novel Therapeutic Strategies for Reducing Right Heart Failure Associated Mortality in Fibrotic Lung Diseases. Biomed Res Int. 2015; 2015:929170.
    View in: PubMed
    Score: 0.015
  37. Inflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apnea. Mediators Inflamm. 2015; 2015:510105.
    View in: PubMed
    Score: 0.015
  38. Echocardiographic evaluation of calcific aortic stenosis in the older adult. Echocardiography. 2011 Jan; 28(1):117-29.
    View in: PubMed
    Score: 0.011
  39. Update of the international multidisciplinary classification of the interstitial pneumonias: an ERS/ATS statement. Eur Respir J. 2025 Dec; 66(6).
    View in: PubMed
    Score: 0.008
  40. Genetics of interstitial lung diseases: a state-of-the-art review. Eur Respir J. 2025 Sep; 66(3).
    View in: PubMed
    Score: 0.008
  41. Proteomic Biomarkers of Survival in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease. Am J Respir Crit Care Med. 2025 Aug; 211(8):1452-1462.
    View in: PubMed
    Score: 0.008
  42. Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement. Am J Respir Crit Care Med. 2025 Jul; 211(7):1132-1155.
    View in: PubMed
    Score: 0.007
  43. Triaging acute chest syndrome clinical decision-making using bedside SaO2/FiO2 ratio. Blood Adv. 2025 Jun 24; 9(12):2970-2979.
    View in: PubMed
    Score: 0.007
  44. Accelerated epigenetic ageing worsens survival and mediates environmental stressors in fibrotic interstitial lung disease. Eur Respir J. 2025 Jun; 65(6).
    View in: PubMed
    Score: 0.007
  45. Elevated blood anandamide levels in acute COVID-19 pneumonia with respiratory failure. Am J Med Sci. 2025 Sep; 370(3):271-277.
    View in: PubMed
    Score: 0.007
  46. Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validation. Lancet Respir Med. 2025 Jun; 13(6):495-504.
    View in: PubMed
    Score: 0.007
  47. Identification of progressive pulmonary fibrosis: consensus findings from a modified Delphi study. Respir Res. 2024 Dec 31; 25(1):448.
    View in: PubMed
    Score: 0.007
  48. Single-Cell Analysis Reveals Novel Immune Perturbations in Fibrotic Hypersensitivity Pneumonitis. Am J Respir Crit Care Med. 2024 Nov 15; 210(10):1252-1266.
    View in: PubMed
    Score: 0.007
  49. Quantitative CT Scan Analysis in Rheumatoid Arthritis-Related Interstitial Lung Disease. Chest. 2025 May; 167(5):1428-1439.
    View in: PubMed
    Score: 0.007
  50. Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation Analysis. Am J Respir Crit Care Med. 2024 Sep 01; 210(5):639-647.
    View in: PubMed
    Score: 0.007
  51. Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease. Am J Respir Crit Care Med. 2024 Aug 15; 210(4):444-454.
    View in: PubMed
    Score: 0.007
  52. The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions. Am J Respir Crit Care Med. 2024 Aug 15; 210(4):392-400.
    View in: PubMed
    Score: 0.007
  53. Molecular Endotypes of Idiopathic Pulmonary Fibrosis: A Latent Class Analysis of Two Multicenter Observational Cohorts. Am J Respir Crit Care Med. 2024 Aug 15; 210(4):455-464.
    View in: PubMed
    Score: 0.007
  54. Hypersensitivity Pneumonitis on Thin-Section Chest CT Scans: Diagnostic Performance of the ATS/JRS/ALAT versus ACCP Imaging Guidelines. Radiol Cardiothorac Imaging. 2024 Aug; 6(4):e230068.
    View in: PubMed
    Score: 0.007
  55. Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2024 05 01; 209(9):1111-1120.
    View in: PubMed
    Score: 0.007
  56. Deep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes. Am J Respir Crit Care Med. 2024 05 01; 209(9):1121-1131.
    View in: PubMed
    Score: 0.007
  57. Risk Factors for Hospital Readmission in Patients With Interstitial Lung Disease. Respir Care. 2024 04 22; 69(5):586-594.
    View in: PubMed
    Score: 0.007
  58. A multidimensional classifier to support lung transplant referral in patients with pulmonary fibrosis. J Heart Lung Transplant. 2024 07; 43(7):1174-1182.
    View in: PubMed
    Score: 0.007
  59. Home Oxygen After Hospitalization for COVID-19: Results From the Multi-Center OXFORD Study. Respir Care. 2024 02 28; 69(3):281-289.
    View in: PubMed
    Score: 0.007
  60. Reply: Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease. Eur Respir J. 2024 Jan; 63(1).
    View in: PubMed
    Score: 0.007
  61. Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2024 01 15; 209(2):137-152.
    View in: PubMed
    Score: 0.007
  62. Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis. Ann Am Thorac Soc. 2023 12; 20(12):1683-1693.
    View in: PubMed
    Score: 0.007
  63. Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease. Eur Respir J. 2023 11; 62(5).
    View in: PubMed
    Score: 0.007
  64. Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary Fibrosis. Chest. 2024 03; 165(3):621-631.
    View in: PubMed
    Score: 0.007
  65. A Deep Learning-Based Radiomic Classifier for Usual Interstitial Pneumonia. Chest. 2024 02; 165(2):371-380.
    View in: PubMed
    Score: 0.007
  66. Identification of Clinically Significant Cytokine Signature Clusters in Patients With Septic Shock. Crit Care Med. 2023 12 01; 51(12):e253-e263.
    View in: PubMed
    Score: 0.007
  67. Towards a Race-Neutral System of Pulmonary Function Test Results Interpretation. Chest. 2023 09; 164(3):727-733.
    View in: PubMed
    Score: 0.006
  68. PCSK6 and Survival in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2023 06 01; 207(11):1515-1524.
    View in: PubMed
    Score: 0.006
  69. Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia. Chest. 2023 05; 163(5):1156-1165.
    View in: PubMed
    Score: 0.006
  70. Validation of Proposed Criteria for Progressive Pulmonary Fibrosis. Am J Respir Crit Care Med. 2023 01 01; 207(1):69-76.
    View in: PubMed
    Score: 0.006
  71. Updated Imaging Classification of Hypersensitivity Pneumonitis. Radiol Clin North Am. 2022 Nov; 60(6):901-913.
    View in: PubMed
    Score: 0.006
  72. Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study. Lancet Respir Med. 2023 01; 11(1):65-73.
    View in: PubMed
    Score: 0.006
  73. MUC5B, telomere length and longitudinal quantitative interstitial lung changes: the MESA Lung Study. Thorax. 2023 06; 78(6):566-573.
    View in: PubMed
    Score: 0.006
  74. Integration and Application of Clinical Practice Guidelines for the Diagnosis of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis. Chest. 2022 09; 162(3):614-629.
    View in: PubMed
    Score: 0.006
  75. Lung function trajectory in progressive fibrosing interstitial lung disease. Eur Respir J. 2022 06; 59(6).
    View in: PubMed
    Score: 0.006
  76. Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis. Respirology. 2022 08; 27(8):635-644.
    View in: PubMed
    Score: 0.006
  77. Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study. Chest. 2022 07; 162(1):145-155.
    View in: PubMed
    Score: 0.006
  78. Hospitalizations in patients with idiopathic pulmonary fibrosis. Respir Res. 2021 Sep 30; 22(1):257.
    View in: PubMed
    Score: 0.006
  79. Treatment of fibrotic interstitial lung disease: current approaches and future directions. Lancet. 2021 10 16; 398(10309):1450-1460.
    View in: PubMed
    Score: 0.006
  80. SARS-CoV-2 Infection Is Associated with Reduced Krüppel-like Factor 2 in Human Lung Autopsy. Am J Respir Cell Mol Biol. 2021 08; 65(2):222-226.
    View in: PubMed
    Score: 0.006
  81. Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells. Am J Respir Crit Care Med. 2021 07 15; 204(2):197-208.
    View in: PubMed
    Score: 0.006
  82. A series of COVID-19 autopsies with clinical and pathologic comparisons to both seasonal and pandemic influenza. J Pathol Clin Res. 2021 09; 7(5):459-470.
    View in: PubMed
    Score: 0.006
  83. Vessel-related structures predict UIP pathology in those with a non-IPF pattern on CT. Eur Radiol. 2021 Oct; 31(10):7295-7302.
    View in: PubMed
    Score: 0.006
  84. Characteristics and Prevalence of Domestic and Occupational Inhalational Exposures Across Interstitial Lung Diseases. Chest. 2021 07; 160(1):209-218.
    View in: PubMed
    Score: 0.006
  85. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2020 03 01; 201(5):564-574.
    View in: PubMed
    Score: 0.005
  86. Circulating Plasma Biomarkers of Progressive Interstitial Lung Disease. Am J Respir Crit Care Med. 2020 01 15; 201(2):250-253.
    View in: PubMed
    Score: 0.005
  87. Diagnostic test interpretation and referral delay in patients with interstitial lung disease. Respir Res. 2019 Nov 12; 20(1):253.
    View in: PubMed
    Score: 0.005
  88. Rare Protein-Altering Telomere-related Gene Variants in Patients with Chronic Hypersensitivity Pneumonitis. Am J Respir Crit Care Med. 2019 11 01; 200(9):1154-1163.
    View in: PubMed
    Score: 0.005
  89. Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary Fibrosis. Chest. 2019 10; 156(4):715-723.
    View in: PubMed
    Score: 0.005
  90. Telomere length and genetic variant associations with interstitial lung disease progression and survival. Eur Respir J. 2019 04; 53(4).
    View in: PubMed
    Score: 0.005
  91. Anti-RNA binding protein positivity in idiopathic interstitial pneumonia. Respir Med. 2019 01; 146:23-27.
    View in: PubMed
    Score: 0.005
  92. Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography. Ann Am Thorac Soc. 2018 06; 15(6):764-766.
    View in: PubMed
    Score: 0.005
  93. CT-Pathologic Correlation of Major Types of Pulmonary Fibrosis: Insights for Revisions to Current Guidelines. AJR Am J Roentgenol. 2018 May; 210(5):1034-1041.
    View in: PubMed
    Score: 0.005
  94. N-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumonia. BMC Pulm Med. 2018 Feb 08; 18(1):30.
    View in: PubMed
    Score: 0.004
  95. CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis. AJR Am J Roentgenol. 2018 Feb; 210(2):307-313.
    View in: PubMed
    Score: 0.004
  96. De Novo Development of Bronchiectasis in Patients With Hematologic Malignancy. Chest. 2017 09; 152(3):683-685.
    View in: PubMed
    Score: 0.004
  97. CT findings associated with survival in chronic hypersensitivity pneumonitis. Eur Radiol. 2017 Dec; 27(12):5127-5135.
    View in: PubMed
    Score: 0.004
  98. ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s. Mucosal Immunol. 2018 01; 11(1):61-70.
    View in: PubMed
    Score: 0.004
  99. CT Findings, Radiologic-Pathologic Correlation, and Imaging Predictors of Survival for Patients With Interstitial Pneumonia With Autoimmune Features. AJR Am J Roentgenol. 2017 Jun; 208(6):1229-1236.
    View in: PubMed
    Score: 0.004
  100. A call for uniformity in implementing the IPAF (interstitial pneumonia with autoimmune features) criteria. Eur Respir J. 2016 12; 48(6):1813-1814.
    View in: PubMed
    Score: 0.004
  101. Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease. Respir Med. 2016 12; 121:117-122.
    View in: PubMed
    Score: 0.004
  102. Imaging of Hypersensitivity Pneumonitis. Radiol Clin North Am. 2016 Nov; 54(6):1033-1046.
    View in: PubMed
    Score: 0.004
  103. Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J. 2016 06; 47(6):1767-75.
    View in: PubMed
    Score: 0.004
  104. The role of echocardiography in the evaluation and management of aortic stenosis in the older adult. Int J Cardiol. 2012 Feb 23; 155(1):39-48.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.